News
RBC Capital Reiterates Sector Perform on Bausch Health Companies, Maintains $12 Price Target
12 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Bausch Health Companies Appeals Court Ruling Out On Bausch Health/Salix Vs Norwich On Xifaxan
11 Apr 24
Biotech, News, Legal, Trading Ideas, General
Acne Vulgaris Treatment PrARAZLO Now Available To Patients Through British Columbia PharmaCare Public Drug Plan
11 Apr 24
Biotech, News, Global, General
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
5 Apr 24
News, Legal
RBC Capital Maintains Sector Perform on Bausch Health Companies, Raises Price Target to $12
5 Apr 24
News, Price Target, Analyst Ratings
RBC Capital Maintains Sector Perform Rating for Bausch Health Companies: Here's What You Need To Know
23 Feb 24
Analyst Ratings
RBC Capital Maintains Sector Perform on Bausch Health Companies, Raises Price Target to $9
23 Feb 24
News, Price Target, Analyst Ratings
Bausch Health Companies Q4 Sales $2.41B Beat $2.30B Estimate, Adjusted Net Income Of $406M
22 Feb 24
Earnings, News
Earnings Scheduled For February 22, 2024
22 Feb 24
Earnings
Preview: Bausch Health Companies's Earnings
21 Feb 24
Earnings
A 'Toxic Byproduct of an Imperfect Higher Education System' — Famous Short Seller Known as 'The Assassin' Strikes Her Newest Target
8 Feb 24
Startups
CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the US
30 Jan 24
Government, News, Regulations
Press releases
Bausch Health to Announce First-Quarter 2024 Results on May 2
11 Apr 24
Earnings, Press Releases
Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029
11 Apr 24
Legal, Press Releases
Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan
11 Apr 24
News, Press Releases
Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals
5 Apr 24
Legal, Press Releases
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
3 Apr 24
News, Press Releases
Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations
2 Apr 24
News, Press Releases
Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma
6 Mar 24
Contracts, Press Releases
New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure
5 Mar 24
Contracts, Press Releases
Bausch Health Companies to Present at Cowen Annual Health Care Conference
1 Mar 24
Events, Press Releases
Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results
22 Feb 24
Earnings, Press Releases
Bausch Health Announces Board Refreshment
1 Feb 24
Management, Press Releases
Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22
1 Feb 24
Earnings, Press Releases
CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S.
30 Jan 24
News, Press Releases